

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 8.51426963 |
| 2 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 7.84451728 |
| 3 | actin nucleation (GO:0045010) | 6.54286433 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.41708832 |
| 5 | T cell migration (GO:0072678) | 6.24168186 |
| 6 | negative T cell selection (GO:0043383) | 6.10912820 |
| 7 | gonadal mesoderm development (GO:0007506) | 5.75516076 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.53769292 |
| 9 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.53241963 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.48016030 |
| 11 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.44043434 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.41220560 |
| 13 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.35588042 |
| 14 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.35588042 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.35179319 |
| 16 | negative thymic T cell selection (GO:0045060) | 5.28247740 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.22509848 |
| 18 | cytidine metabolic process (GO:0046087) | 5.21959757 |
| 19 | cytidine catabolic process (GO:0006216) | 5.21959757 |
| 20 | cytidine deamination (GO:0009972) | 5.21959757 |
| 21 | positive T cell selection (GO:0043368) | 5.06286124 |
| 22 | sequestering of actin monomers (GO:0042989) | 5.02525074 |
| 23 | negative regulation of cell killing (GO:0031342) | 4.91599584 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.91599584 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.83092748 |
| 26 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.78110282 |
| 27 | negative regulation of stress fiber assembly (GO:0051497) | 4.70405815 |
| 28 | positive regulation of lamellipodium assembly (GO:0010592) | 4.65621700 |
| 29 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.63918692 |
| 30 | T cell selection (GO:0045058) | 4.57097758 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.56244469 |
| 32 | positive thymic T cell selection (GO:0045059) | 4.50258025 |
| 33 | DNA deamination (GO:0045006) | 4.40101662 |
| 34 | tolerance induction (GO:0002507) | 4.38647195 |
| 35 | thymic T cell selection (GO:0045061) | 4.34708395 |
| 36 | cellular response to interleukin-15 (GO:0071350) | 4.34636524 |
| 37 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.32951382 |
| 38 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.31071811 |
| 39 | leukocyte aggregation (GO:0070486) | 4.25138755 |
| 40 | regulation of defense response to virus by virus (GO:0050690) | 4.24430731 |
| 41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.16369815 |
| 42 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.06053717 |
| 43 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.05930241 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.99500683 |
| 45 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.98171414 |
| 46 | response to interleukin-15 (GO:0070672) | 3.96949395 |
| 47 | negative regulation of phagocytosis (GO:0050765) | 3.96483043 |
| 48 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.95350187 |
| 49 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.90257935 |
| 50 | T cell receptor signaling pathway (GO:0050852) | 3.89715562 |
| 51 | activated T cell proliferation (GO:0050798) | 3.89294119 |
| 52 | cytolysis (GO:0019835) | 3.87479378 |
| 53 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.84682148 |
| 54 | positive regulation of cell killing (GO:0031343) | 3.78743425 |
| 55 | negative regulation of T cell apoptotic process (GO:0070233) | 3.75284086 |
| 56 | lymphocyte chemotaxis (GO:0048247) | 3.70558082 |
| 57 | regulation of T cell tolerance induction (GO:0002664) | 3.66536157 |
| 58 | lymphocyte migration (GO:0072676) | 3.64685021 |
| 59 | chemokine-mediated signaling pathway (GO:0070098) | 3.62701993 |
| 60 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.55340636 |
| 61 | respiratory burst (GO:0045730) | 3.55122841 |
| 62 | cellular defense response (GO:0006968) | 3.49121957 |
| 63 | regulation of cell killing (GO:0031341) | 3.44052641 |
| 64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.42851080 |
| 65 | T cell costimulation (GO:0031295) | 3.42844194 |
| 66 | positive regulation of lamellipodium organization (GO:1902745) | 3.42429461 |
| 67 | lymphocyte costimulation (GO:0031294) | 3.38711705 |
| 68 | mature B cell differentiation involved in immune response (GO:0002313) | 3.34467185 |
| 69 | positive regulation of translational initiation (GO:0045948) | 3.33265314 |
| 70 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.28744094 |
| 71 | execution phase of apoptosis (GO:0097194) | 3.28144470 |
| 72 | Peyers patch development (GO:0048541) | 3.25714864 |
| 73 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.25714864 |
| 74 | positive regulation of B cell differentiation (GO:0045579) | 3.23520290 |
| 75 | positive regulation of tolerance induction (GO:0002645) | 3.18903789 |
| 76 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18879419 |
| 77 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.11689498 |
| 78 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.09575978 |
| 79 | T cell mediated immunity (GO:0002456) | 3.08787800 |
| 80 | B cell receptor signaling pathway (GO:0050853) | 3.08546036 |
| 81 | regulation of tolerance induction (GO:0002643) | 3.07311539 |
| 82 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.06066976 |
| 83 | regulation of B cell differentiation (GO:0045577) | 3.05027789 |
| 84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.02403321 |
| 85 | regulation of calcium-mediated signaling (GO:0050848) | 3.02007090 |
| 86 | T cell differentiation (GO:0030217) | 2.97996633 |
| 87 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.97042599 |
| 88 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.97039791 |
| 89 | positive regulation of actin filament polymerization (GO:0030838) | 2.96878086 |
| 90 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.95113954 |
| 91 | regulation of T cell chemotaxis (GO:0010819) | 2.92341771 |
| 92 | positive regulation of T cell chemotaxis (GO:0010820) | 2.92341771 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.87458730 |
| 94 | negative regulation of telomere maintenance (GO:0032205) | 2.86177810 |
| 95 | regulation of activation of Janus kinase activity (GO:0010533) | 2.85181901 |
| 96 | natural killer cell differentiation (GO:0001779) | 2.84870565 |
| 97 | negative regulation of type 2 immune response (GO:0002829) | 2.84045204 |
| 98 | negative regulation of viral genome replication (GO:0045071) | 2.82215652 |
| 99 | dendritic cell chemotaxis (GO:0002407) | 2.81117430 |
| 100 | T cell activation (GO:0042110) | 2.80750206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.84070717 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.47696154 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.24187504 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 5.21356615 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.28169275 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.57125000 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.52913719 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.52320505 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.49973545 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.49720662 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.37531662 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.10590588 |
| 13 | UTX_26944678_Chip-Seq_JUKART_Human | 2.87330070 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69256518 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.57343910 |
| 16 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.57196837 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.56153727 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.49819383 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45886034 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.43113138 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.39635439 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24951470 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13850666 |
| 24 | GATA3_26560356_Chip-Seq_TH2_Human | 2.04191066 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.02678141 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97391402 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.96666456 |
| 28 | MAF_26560356_Chip-Seq_TH2_Human | 1.93743824 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78067665 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75510630 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75277033 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.74344561 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.72242378 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60538944 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57691750 |
| 36 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.56069037 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55294128 |
| 38 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.54611395 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52770372 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.51376596 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45735893 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.44178622 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.43697584 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42558561 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42171143 |
| 46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.41293184 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.40512732 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34077759 |
| 49 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32352732 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31733099 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30722190 |
| 52 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30137304 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.24081007 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20908882 |
| 55 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.18004431 |
| 56 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.16526624 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.15699909 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15437397 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12741309 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09820863 |
| 61 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08399862 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07310848 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04248986 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03656920 |
| 65 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.03481631 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01149242 |
| 67 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00251670 |
| 68 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00063254 |
| 69 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98779712 |
| 70 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.98188932 |
| 71 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98111864 |
| 72 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95379116 |
| 73 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92574239 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90119215 |
| 75 | P300_27268052_Chip-Seq_Bcells_Human | 0.89402643 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88732089 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88575422 |
| 78 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87873513 |
| 79 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.87637727 |
| 80 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.85205336 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85064692 |
| 82 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83811934 |
| 83 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82089499 |
| 84 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80257815 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80156271 |
| 86 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.78954171 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78393198 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77446440 |
| 89 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.76982840 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76669938 |
| 91 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76240009 |
| 92 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.75960773 |
| 93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.75324003 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.75320311 |
| 95 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74743961 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.74682881 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74188706 |
| 98 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70954948 |
| 99 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.70322917 |
| 100 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.69896796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.24503360 |
| 2 | MP0009785_altered_susceptibility_to | 4.31920565 |
| 3 | MP0003763_abnormal_thymus_physiology | 4.21007026 |
| 4 | MP0002166_altered_tumor_susceptibility | 3.65313892 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.48368953 |
| 6 | MP0001800_abnormal_humoral_immune | 3.02529002 |
| 7 | MP0005025_abnormal_response_to | 3.01106522 |
| 8 | MP0001790_abnormal_immune_system | 2.93953489 |
| 9 | MP0005387_immune_system_phenotype | 2.93953489 |
| 10 | MP0000685_abnormal_immune_system | 2.90801410 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.85314532 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.82755646 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.74448285 |
| 14 | MP0001819_abnormal_immune_cell | 2.65430779 |
| 15 | MP0003724_increased_susceptibility_to | 2.56188105 |
| 16 | MP0002723_abnormal_immune_serum | 2.53664132 |
| 17 | MP0002006_tumorigenesis | 2.52485572 |
| 18 | MP0003436_decreased_susceptibility_to | 2.50894261 |
| 19 | MP0004147_increased_porphyrin_level | 2.50303665 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.41120414 |
| 21 | MP0003866_abnormal_defecation | 2.40558397 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.38150782 |
| 23 | MP0002398_abnormal_bone_marrow | 2.24537513 |
| 24 | MP0003045_fibrosis | 2.17582486 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.14910963 |
| 26 | MP0002405_respiratory_system_inflammati | 2.14452196 |
| 27 | MP0002419_abnormal_innate_immunity | 2.06842798 |
| 28 | MP0006082_CNS_inflammation | 2.05582020 |
| 29 | MP0003448_altered_tumor_morphology | 1.98945662 |
| 30 | MP0000716_abnormal_immune_system | 1.97954473 |
| 31 | MP0002009_preneoplasia | 1.92524393 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.84898070 |
| 33 | MP0002722_abnormal_immune_system | 1.84206898 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.77532707 |
| 35 | MP0004947_skin_inflammation | 1.74025936 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.72201946 |
| 37 | MP0002933_joint_inflammation | 1.68419583 |
| 38 | MP0001542_abnormal_bone_strength | 1.59219801 |
| 39 | MP0002429_abnormal_blood_cell | 1.58451507 |
| 40 | MP0008469_abnormal_protein_level | 1.52448533 |
| 41 | MP0002132_abnormal_respiratory_system | 1.32792281 |
| 42 | MP0005166_decreased_susceptibility_to | 1.32183979 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.24499236 |
| 44 | MP0009763_increased_sensitivity_to | 1.21912827 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.21389450 |
| 46 | MP0000858_altered_metastatic_potential | 1.19842096 |
| 47 | MP0003011_delayed_dark_adaptation | 1.19248881 |
| 48 | MP0000604_amyloidosis | 1.14226916 |
| 49 | MP0003329_amyloid_beta_deposits | 1.09990670 |
| 50 | MP0001873_stomach_inflammation | 1.08332352 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.07771061 |
| 52 | MP0003303_peritoneal_inflammation | 1.04079362 |
| 53 | MP0002693_abnormal_pancreas_physiology | 1.02536268 |
| 54 | MP0003806_abnormal_nucleotide_metabolis | 0.98003510 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 0.97790822 |
| 56 | MP0009764_decreased_sensitivity_to | 0.96135468 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 0.94651519 |
| 58 | MP0004883_abnormal_blood_vessel | 0.93029177 |
| 59 | MP0010386_abnormal_urinary_bladder | 0.89367680 |
| 60 | MP0004381_abnormal_hair_follicle | 0.88667296 |
| 61 | MP0000490_abnormal_crypts_of | 0.85513765 |
| 62 | MP0001853_heart_inflammation | 0.83582851 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.82270586 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 0.82120130 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 0.81960231 |
| 66 | MP0003252_abnormal_bile_duct | 0.79852264 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 0.77777116 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 0.77690972 |
| 69 | MP0004130_abnormal_muscle_cell | 0.76937749 |
| 70 | MP0004142_abnormal_muscle_tone | 0.76666063 |
| 71 | MP0001919_abnormal_reproductive_system | 0.76208016 |
| 72 | MP0002168_other_aberrant_phenotype | 0.69611789 |
| 73 | MP0009643_abnormal_urine_homeostasis | 0.68136967 |
| 74 | MP0002019_abnormal_tumor_incidence | 0.68047845 |
| 75 | MP0005058_abnormal_lysosome_morphology | 0.67838603 |
| 76 | MP0001968_abnormal_touch/_nociception | 0.67012133 |
| 77 | MP0003137_abnormal_impulse_conducting | 0.65647370 |
| 78 | MP0000678_abnormal_parathyroid_gland | 0.65537763 |
| 79 | MP0008260_abnormal_autophagy | 0.64222694 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.63908568 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 0.62607264 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 0.62595462 |
| 83 | MP0001851_eye_inflammation | 0.62106734 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.61956151 |
| 85 | MP0005310_abnormal_salivary_gland | 0.59129059 |
| 86 | MP0002736_abnormal_nociception_after | 0.57814763 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 0.54745678 |
| 88 | MP0003878_abnormal_ear_physiology | 0.52714058 |
| 89 | MP0005377_hearing/vestibular/ear_phenot | 0.52714058 |
| 90 | MP0001243_abnormal_dermal_layer | 0.52450139 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.50550930 |
| 92 | MP0008873_increased_physiological_sensi | 0.48655848 |
| 93 | MP0005164_abnormal_response_to | 0.47940236 |
| 94 | MP0005266_abnormal_metabolism | 0.47730200 |
| 95 | MP0003690_abnormal_glial_cell | 0.47116384 |
| 96 | MP0003795_abnormal_bone_structure | 0.46589662 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 0.45060732 |
| 98 | MP0008874_decreased_physiological_sensi | 0.44402313 |
| 99 | MP0009697_abnormal_copulation | 0.43984176 |
| 100 | MP0003191_abnormal_cellular_cholesterol | 0.43915831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 6.98381510 |
| 2 | Aplastic anemia (HP:0001915) | 6.27250586 |
| 3 | T lymphocytopenia (HP:0005403) | 5.99323464 |
| 4 | IgG deficiency (HP:0004315) | 5.52435265 |
| 5 | Acute hepatic failure (HP:0006554) | 5.29689874 |
| 6 | Spontaneous hematomas (HP:0007420) | 5.28485850 |
| 7 | Abnormality of T cell number (HP:0011839) | 5.26069586 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.00630416 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 4.68220760 |
| 10 | Autoimmune hemolytic anemia (HP:0001890) | 4.58281846 |
| 11 | Encephalitis (HP:0002383) | 4.49728041 |
| 12 | Chronic diarrhea (HP:0002028) | 4.37858701 |
| 13 | Stomatitis (HP:0010280) | 4.04516089 |
| 14 | Abnormality of T cells (HP:0002843) | 4.00410604 |
| 15 | Broad face (HP:0000283) | 3.92566770 |
| 16 | Hypergammaglobulinemia (HP:0010702) | 3.91358529 |
| 17 | B lymphocytopenia (HP:0010976) | 3.85364491 |
| 18 | Combined immunodeficiency (HP:0005387) | 3.62781631 |
| 19 | Abnormality of B cell number (HP:0010975) | 3.56332602 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.53295468 |
| 21 | IgM deficiency (HP:0002850) | 3.47415476 |
| 22 | Pancytopenia (HP:0001876) | 3.43593321 |
| 23 | Meningitis (HP:0001287) | 3.43362439 |
| 24 | Myositis (HP:0100614) | 3.38957429 |
| 25 | Recurrent viral infections (HP:0004429) | 3.33231659 |
| 26 | Increased IgE level (HP:0003212) | 3.32647718 |
| 27 | Thyroiditis (HP:0100646) | 3.32436630 |
| 28 | 3-Methylglutaconic aciduria (HP:0003535) | 3.28729641 |
| 29 | Lymphoma (HP:0002665) | 3.23556495 |
| 30 | Cellular immunodeficiency (HP:0005374) | 3.23382246 |
| 31 | Eczematoid dermatitis (HP:0000976) | 3.08586771 |
| 32 | Pustule (HP:0200039) | 3.06090069 |
| 33 | Recurrent bronchitis (HP:0002837) | 3.05846888 |
| 34 | Lymphopenia (HP:0001888) | 3.04828936 |
| 35 | Microcytic anemia (HP:0001935) | 2.99811263 |
| 36 | Hypoproteinemia (HP:0003075) | 2.98309951 |
| 37 | Eosinophilia (HP:0001880) | 2.89649313 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.89367914 |
| 39 | Abnormality of eosinophils (HP:0001879) | 2.86605229 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.85818343 |
| 41 | Petechiae (HP:0000967) | 2.76303893 |
| 42 | Obstructive lung disease (HP:0006536) | 2.71729520 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71729520 |
| 44 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.70832808 |
| 45 | Cerebral palsy (HP:0100021) | 2.69553616 |
| 46 | Oral leukoplakia (HP:0002745) | 2.69106309 |
| 47 | Cerebral hypomyelination (HP:0006808) | 2.65891425 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.64937306 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.59656018 |
| 50 | Recurrent bacterial skin infections (HP:0005406) | 2.58975885 |
| 51 | Symptomatic seizures (HP:0011145) | 2.58308840 |
| 52 | Leukocytosis (HP:0001974) | 2.54613266 |
| 53 | Granulocytopenia (HP:0001913) | 2.50162226 |
| 54 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.47042232 |
| 55 | Tetany (HP:0001281) | 2.44327180 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.37814042 |
| 57 | Parakeratosis (HP:0001036) | 2.34679128 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.34674578 |
| 59 | Hypoplasia of the thymus (HP:0000778) | 2.27844571 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.27167049 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.25888532 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.25888532 |
| 63 | Hemoptysis (HP:0002105) | 2.23291523 |
| 64 | Retrobulbar optic neuritis (HP:0100654) | 2.19049346 |
| 65 | Optic neuritis (HP:0100653) | 2.19049346 |
| 66 | Vasculitis (HP:0002633) | 2.18815009 |
| 67 | Abolished electroretinogram (ERG) (HP:0000550) | 2.15566188 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15207039 |
| 69 | Conjunctival telangiectasia (HP:0000524) | 2.14440152 |
| 70 | Pulmonary embolism (HP:0002204) | 2.14064302 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.12994836 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.08214189 |
| 73 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.08147536 |
| 74 | Abnormality of the columella (HP:0009929) | 2.06228283 |
| 75 | Orchitis (HP:0100796) | 2.05182179 |
| 76 | Hepatitis (HP:0012115) | 2.04202828 |
| 77 | Progressive neurologic deterioration (HP:0002344) | 2.03476802 |
| 78 | Epistaxis (HP:0000421) | 2.02125917 |
| 79 | Pulmonary infiltrates (HP:0002113) | 1.99753739 |
| 80 | Long clavicles (HP:0000890) | 1.99728564 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 1.95941185 |
| 82 | Recurrent skin infections (HP:0001581) | 1.93395589 |
| 83 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.92942505 |
| 84 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.92942505 |
| 85 | Increased intramyocellular lipid droplets (HP:0012240) | 1.92923928 |
| 86 | Spinal canal stenosis (HP:0003416) | 1.92428652 |
| 87 | Birth length less than 3rd percentile (HP:0003561) | 1.92067096 |
| 88 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91646162 |
| 89 | Keratoconjunctivitis (HP:0001096) | 1.90596527 |
| 90 | Nasal polyposis (HP:0100582) | 1.87497762 |
| 91 | Hypochromic microcytic anemia (HP:0004840) | 1.86872018 |
| 92 | Abnormality of the pleura (HP:0002103) | 1.84699735 |
| 93 | Generalized aminoaciduria (HP:0002909) | 1.80728128 |
| 94 | Chest pain (HP:0100749) | 1.80728049 |
| 95 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80285648 |
| 96 | Joint swelling (HP:0001386) | 1.79108488 |
| 97 | Acne (HP:0001061) | 1.77646804 |
| 98 | Anorexia (HP:0002039) | 1.76892163 |
| 99 | Vacuolated lymphocytes (HP:0001922) | 1.76470065 |
| 100 | Agammaglobulinemia (HP:0004432) | 1.76158370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 5.80821679 |
| 2 | KDR | 5.43785807 |
| 3 | MAP3K12 | 5.27636547 |
| 4 | MAP4K1 | 3.59561595 |
| 5 | TESK1 | 3.41415730 |
| 6 | GRK7 | 2.99126364 |
| 7 | TXK | 2.73208999 |
| 8 | BLK | 2.45222054 |
| 9 | ITK | 2.33565945 |
| 10 | MAP3K11 | 2.13622418 |
| 11 | TGFBR2 | 2.12928844 |
| 12 | FES | 2.06165542 |
| 13 | STK10 | 1.93963836 |
| 14 | CSK | 1.89223211 |
| 15 | RIPK4 | 1.74528512 |
| 16 | LIMK1 | 1.66756645 |
| 17 | MOS | 1.66195576 |
| 18 | MYLK | 1.63398615 |
| 19 | TAOK3 | 1.61643584 |
| 20 | ZAP70 | 1.60079209 |
| 21 | BUB1 | 1.52070092 |
| 22 | CAMKK2 | 1.50623582 |
| 23 | GRK6 | 1.48941973 |
| 24 | BTK | 1.43634381 |
| 25 | CLK1 | 1.42865133 |
| 26 | MAP3K10 | 1.33819247 |
| 27 | LCK | 1.23220447 |
| 28 | SYK | 1.22994396 |
| 29 | JAK3 | 1.16201287 |
| 30 | TBK1 | 1.14905093 |
| 31 | PASK | 1.10170743 |
| 32 | LYN | 1.05302314 |
| 33 | TAF1 | 1.05152254 |
| 34 | HCK | 1.03958960 |
| 35 | MAP3K5 | 1.01179047 |
| 36 | TYK2 | 1.00078139 |
| 37 | SCYL2 | 0.97126756 |
| 38 | RPS6KA4 | 0.93854250 |
| 39 | GRK5 | 0.93311244 |
| 40 | TYRO3 | 0.84258442 |
| 41 | JAK2 | 0.81722744 |
| 42 | PTK6 | 0.81691566 |
| 43 | TEC | 0.81515150 |
| 44 | WNK4 | 0.80868543 |
| 45 | MAP3K3 | 0.77636688 |
| 46 | TAOK2 | 0.76520098 |
| 47 | MAPK11 | 0.74279650 |
| 48 | PRKCH | 0.73082874 |
| 49 | NTRK2 | 0.71548902 |
| 50 | PAK4 | 0.71318544 |
| 51 | DAPK1 | 0.69759985 |
| 52 | PRKCQ | 0.69102543 |
| 53 | IKBKE | 0.68703514 |
| 54 | BCKDK | 0.68022458 |
| 55 | ILK | 0.67346122 |
| 56 | MAP2K3 | 0.65382184 |
| 57 | CSF1R | 0.64080787 |
| 58 | MAPKAPK2 | 0.63558805 |
| 59 | SIK3 | 0.63228458 |
| 60 | ADRBK2 | 0.63199026 |
| 61 | TAOK1 | 0.62980245 |
| 62 | IRAK4 | 0.62166212 |
| 63 | CAMKK1 | 0.60304158 |
| 64 | ERN1 | 0.58271664 |
| 65 | PDK1 | 0.58100369 |
| 66 | JAK1 | 0.56951623 |
| 67 | AURKA | 0.50524709 |
| 68 | FYN | 0.49559183 |
| 69 | PAK1 | 0.49485071 |
| 70 | CDK4 | 0.49207968 |
| 71 | NEK6 | 0.49027360 |
| 72 | PIM1 | 0.47889628 |
| 73 | MAPKAPK3 | 0.44938630 |
| 74 | BRSK1 | 0.43733029 |
| 75 | TNK2 | 0.40538185 |
| 76 | TRPM7 | 0.38012454 |
| 77 | MELK | 0.34955664 |
| 78 | PRPF4B | 0.34673812 |
| 79 | MARK3 | 0.34162409 |
| 80 | GRK1 | 0.33663001 |
| 81 | MST4 | 0.33375852 |
| 82 | RPS6KA5 | 0.33100965 |
| 83 | EPHB1 | 0.33046607 |
| 84 | TRIM28 | 0.32281120 |
| 85 | MAP3K1 | 0.29264783 |
| 86 | KIT | 0.27974912 |
| 87 | BMPR2 | 0.26803402 |
| 88 | IKBKB | 0.25498315 |
| 89 | CDK6 | 0.25261663 |
| 90 | MAP2K2 | 0.24693749 |
| 91 | ADRBK1 | 0.23965207 |
| 92 | INSR | 0.23684895 |
| 93 | ROCK1 | 0.23314056 |
| 94 | FGR | 0.22892312 |
| 95 | NLK | 0.22724965 |
| 96 | DYRK1B | 0.22146462 |
| 97 | EIF2AK3 | 0.20983991 |
| 98 | DAPK2 | 0.20681797 |
| 99 | STK39 | 0.20162818 |
| 100 | CSNK2A1 | 0.18213739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.98835559 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.55037783 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.19403717 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.09797854 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.07170262 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.76402705 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.71227681 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.54082989 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.51753464 |
| 10 | Shigellosis_Homo sapiens_hsa05131 | 2.38456344 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.25020770 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.01719874 |
| 13 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.99378271 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82461929 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.82249861 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.81156173 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.77107168 |
| 18 | Salmonella infection_Homo sapiens_hsa05132 | 1.73101426 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56550475 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.53754753 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49977580 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.49509309 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47478445 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36062811 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35490169 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.34333938 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.31169654 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28797668 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27576702 |
| 30 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.25095547 |
| 31 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23967383 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23590967 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.19646640 |
| 34 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12244913 |
| 35 | Prion diseases_Homo sapiens_hsa05020 | 1.09548274 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08673535 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.08151280 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05091862 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 0.99177607 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97625010 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96578812 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.94285924 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.94053587 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 0.93529243 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91988974 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 0.90094079 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85040158 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.83400545 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81591757 |
| 50 | Ribosome_Homo sapiens_hsa03010 | 0.80942439 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.80217463 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78650979 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78383690 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77440648 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76266154 |
| 56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75279586 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.74109011 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74096661 |
| 59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72602254 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72322545 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71612388 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71566069 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71540191 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.63057470 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.60265259 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57137931 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53066882 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52629748 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51449904 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36116539 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35404176 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35393691 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31802856 |
| 74 | DNA replication_Homo sapiens_hsa03030 | 0.30216758 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.26463075 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.26404705 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.25042894 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22502174 |
| 79 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.21956567 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.21560587 |
| 81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.20356567 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.18708260 |
| 83 | RNA polymerase_Homo sapiens_hsa03020 | 0.17219163 |
| 84 | Spliceosome_Homo sapiens_hsa03040 | 0.16719562 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.16499065 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.16258243 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13658041 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.13571963 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.12622099 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.12448954 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.11460835 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.09995669 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.09955485 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.09142458 |
| 95 | Other glycan degradation_Homo sapiens_hsa00511 | 0.09053209 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.08891239 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.08601249 |
| 98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.07912888 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.05806609 |
| 100 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.05297064 |

